Pneumocystis jiroveci pneumonia in an atypical host

Clinical Breast Cancer

Volumn 12, Issue 2, 2012, Pages 138-141

  Reinbolt, Raquel E ^a   Alam, Shadia ^a   Layman, Rachel ^a   Shapiro, Charles ^a   Lustberg, Maryam ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Bendamustine; Breast Cancer; PCP; Solid Tumor

Indexed keywords

AZITHROMYCIN; BENDAMUSTINE; BEVACIZUMAB; COTRIMOXAZOLE; DEXAMETHASONE; ERLOTINIB; LEVOFLOXACIN; PACLITAXEL;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; LUNG METASTASIS; LYMPHOCYTOPENIA; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; RARE DISEASE; SOLID TUMOR;

EID: 84858952290     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2011.10.003     Document Type: Article

References (28)

1. Vanek J, Jirovec O. Parasitic pneumoni. Interstitial plasma cell pneumonia of premature, caused by Pneumocystis carinii. Zentralbl Bakteriol Parasitenkd Infektionskr Hyg 1952; 158:120.
2. Giese W. Pathogenese und aetiologie der interstitiellen plasmacellulaeren Saeuglingspneumonie. Verh Deutsch Ges Pathol 1953; 36:284.
3. Bendamustine and erlotinib in treating patients with stage IIIB, stage IIIC, or stage IV breast cancer. Clinicaltrials.gov [Web site]. Available at: http://clinicaltrials.gov/ct2/show/NCT00834678. Accessed: May 7, 2011.
4. Sepkowitz KA. Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis 1993; 17(suppl 2):S416-S422. (Pubitemid 23322834)
5. Mahindra AK, Grossman SA. Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors. J Neurooncol 2003; 63:263-70. (Pubitemid 36874010)
6. Baez-Escudero JL, Greene JN, Sandin RL, et al. Pneumocystis carinii pneumonia in cancer patients. Abstr Hematol Oncol 2004; 7:24-30.
7. Kulke MH, Vance EA. Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin Infect Dis 1997; 24:215-8. (Pubitemid 127775482)
8. Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 1996; 71:5.
9. Tolaney SM, Partridge AH, Sheib RG, et al. Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer. J Clin Oncol 2006; 24:5330-1. (Pubitemid 46631382)
10. Brunvand MW, Collis C, Livingston RB, et al. Pneumocystis carinii pneumonia associated with profound lymphopenia and abnormal T-lymphocyte subset ratios during treatment for early-stage breast carcinoma. Cancer 1991; 67:2407-9.
11. Schoffski P, Hagedorn T, Grunwald V, et al. Repeated administration of short infusions of bendamustine: a phase I study in patients with advanced progressive solid tumours. J Cancer Res Clin Oncol 2000; 126:41-7. (Pubitemid 30006350)
12. Bremer K, Roth W. Bendamustine, a low-toxic nitrogen mustard derivative with high efficacy in malignant lymphomas. Tumordiagn Ther 1996; 17:1-6. (Pubitemid 26124745)
13. Bergann MA, Goebeler ME, Herold M, et al. Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia. Results of a phase I/II study of the German CLL Study Group. Haematologica 2005; 90:1357-64. (Pubitemid 41503651)
14. Lissitchkov T, Arnaudov G, Peytchev D, et al. Phase I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukemia (binet stages B and C) requiring therapy. J Cancer Res Clin Oncol 2006; 132:99-104. (Pubitemid 41752051)
15. Niederle N, Balleisen L, Heit W, et al. Bendamustine versus fludarabine as second-line treatment for patients with chronic lymphocytic leukemia: first interim results of a randomized study. Ann Oncol 2008; 19:379.
16. Knauf WU, Lissitchkov T, Aldaoud A, et al. Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. J Clin Oncol 2009; 27:4378-84.
17. Klippstein A, Schneider CP, Sayer HG, et al. Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer. J Cancer Res Clin Oncol 2003; 129:316-9. (Pubitemid 36791688)
18. Peereboom DM, Shepard DR, Ahluwalia MS, et al. Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. J Neurooncol 2010; 98:93-9.
19. Green H, Paul M, Vidal L, et al. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 2007; 82:1052.
20. Green H, Paul M, Vidal L, et al. Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 2007; 82:1052-9. (Pubitemid 47357136)
21. Festic E, Gajic O, Limper AH, et al. Acute respiratory failure due to Pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest 2005; 128:573-9. (Pubitemid 41140482)
22. Worth LJ, Dooley MJ, Seymour JF, et al. An analysis of the utilization of chemoprophylaxis against Pneumocystis jirivecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer 2005; 92:867-72. (Pubitemid 40462631)
23. Mansharamani NG, Balachandran D, Vernovsky I, et al. Peripheral blood CD4+ T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 2000; 118:712-20.
24. Mansharamani NG, Garland R, Delaney D, et al. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000; 118:704-11.
25. Woods WG, Daigle AE, Hutchinson RJ, et al. Myelosuppression associated with co-trimoxazole as a prophylactic antibiotic in the maintenance phase of a childhood acute lymphocytic leukemia. J Pediat 1984; 105:639-44. (Pubitemid 14003586)
26. Imrie KR, Prince HM, Couture F, et al. Effect of antimicrobial prophylaxis on hematopoietic recovery following autologous bone marrow transplantation: ciprofloxacin versus co-trimoxazole. Bone Marrow Transplant 1995; 15:267-70.
27. Hughes WT, Kuhn S, Chaudhary S, et al. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1977; 297:1419-26.
28. Hughes WT, Rivera GK, Schell MJ, et al. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 1987; 316:1627-32. (Pubitemid 17082589)